| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/29/2005 | EP1546130A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 06/29/2005 | EP1546103A1 Piperazine and piperidine derivatives for treatment of neurological diseases |
| 06/29/2005 | EP1546101A1 Naphthyl ether compounds and their use |
| 06/29/2005 | EP1546100A1 New benzoyl piperidine compounds |
| 06/29/2005 | EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 06/29/2005 | EP1373272B1 Tert. alkylphenoxy substituted polycyclic compounds |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | CN1633415A Antibacterial mutilins |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633413A 20-hydroxyeicosatetraenoic acid production inhibitors |
| 06/29/2005 | CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/29/2005 | CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/29/2005 | CN1208329C Aniline derivatives |
| 06/29/2005 | CN1208318C Cycloamine CCR5 receptor antagonists |
| 06/29/2005 | CN1208314C Factor VIIA inhibitor (thio) urea derivatives, their preparation and their use |
| 06/28/2005 | US6911544 Amidating L-ornithine with N-methoxy-N-methylamino-containing compound; substance P antagonists |
| 06/28/2005 | US6911478 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 06/28/2005 | US6911477 Muscarinic receptor agonists |
| 06/28/2005 | US6911458 Compounds |
| 06/28/2005 | US6911447 Non-aromatic carbocyclic rings; aromatic carbocyclic rings; non-aromatic heterocyclic rings; aromatic heterocyclic rings; compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 |
| 06/28/2005 | US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 06/23/2005 | WO2005057207A1 Trityl derivatives for enhancing mass spectrometry |
| 06/23/2005 | WO2005056528A1 Carboxamide derivatives |
| 06/23/2005 | WO2005056003A1 Dpp-iv inhibitors |
| 06/23/2005 | WO2005055941A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005055940A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | WO2005033056A3 Triphenylethylene compounds as selective estrogen receptor modulators |
| 06/23/2005 | WO2005016885A3 COMPOUNDS WITH COMBINED CALCIUM CHANNEL BLOCKER AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITIES FOR TREATMENT OF HEART DISEASE |
| 06/23/2005 | WO2004043380A8 Small technetium-99m and rhenium labeled agents and methods for imaging tissues, organs and tumors |
| 06/23/2005 | US20050137405 Reacting o-chlorobenzaldehyde with an alkyl 4-(phthalimido)ethoxy)acetoacetate to yield alkyl 2-(o-chlorobenzylidene)-4-(2-phthalimidoethoxy)acetoacetate which upon reacting with an alkyl -3-aminocrotonate yields a phtahalimiamlodipine; good yields and purity; useful as reference standards or markers |
| 06/23/2005 | US20050137230 Factor Xa-inhibitors; preventing thromboembolic illnesses and tumors; 2-amino-N-(2'-methylsulfonylbiphenyl-4-yl)-3-phenylpropionamide |
| 06/23/2005 | US20050137223 Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| 06/23/2005 | US20050137221 Keratinocyte-proliferative diseases; inhibitor of solubilization of Epidermal Growth Factor; 3,4,5-trihydroxy-1-(4'-methoxybenzenesulfonyl)-piperidine-2-carboxylic acid hydroxamide; 7-acetoxy-5-(4'-methoxybenzenesulfonyl)-2,2-dimethyl-h exahydro-[1,3]dioxolo[4,5-c]pyridine-6-carboxy ester intermediate |
| 06/23/2005 | US20050137210 Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders |
| 06/23/2005 | US20050137208 Chemical compounds |
| 06/23/2005 | US20050137174 Broad spectrum antibiotics; N-t-Butylcarbonyloxymethyl (9-[(2,2, dimethyl-propyl amino)-methyl]-minocycline)carbamate; antiinflammatory, anticarcinogenic, viricde, bactericide; gram positive and gram negative bacterial infection; viral infection; prodrugs |
| 06/23/2005 | US20050135737 Optical interleaver |
| 06/23/2005 | CA2549548A1 Carboxamide derivatives |
| 06/23/2005 | CA2549273A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2549272A1 Novel m3 muscarinic acetylcholine receptor antagonists |
| 06/23/2005 | CA2548742A1 Dpp-iv inhibitors |
| 06/22/2005 | EP1543077A1 Thermoplastic compositions with enhanced melt flow and compatibility |
| 06/22/2005 | EP1542988A1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same |
| 06/22/2005 | EP1542967A1 Amide and sulfonamide ligands for the estrogen receptor |
| 06/22/2005 | EP1542966A1 Aromatic liver x-receptor modulators |
| 06/22/2005 | EP1455787B1 Certain glycine derivatives as factor xa inhibitors for use in the treatment of thrombotic disorders |
| 06/22/2005 | EP1100763B1 Diketoacid-derivatives as inhibitors of polymerases |
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | CN1630629A 酯化合物及其医药用途 Ester compounds and pharmaceutical use |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/22/2005 | CN1207283C 4-aminopiperidine derivatives and their use as medicine |
| 06/22/2005 | CN1207282C Polymorph of polynaphthapiper hydrochloride, preparation method and use thereof |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908922 Linear cyclic ureas |
| 06/21/2005 | US6908911 Antibacterial agents |
| 06/21/2005 | CA2309474C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 06/21/2005 | CA2309473C New 4-arylpiperidine derivatives for the treatment of pruritus |
| 06/16/2005 | WO2005054871A2 Analysis of mass spectral data in the quiet zones |
| 06/16/2005 | WO2005054227A1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
| 06/16/2005 | WO2005054196A1 A Method for the Enantiomoeric Separation of Optical Active Amlodipine |
| 06/16/2005 | WO2005054192A1 Cosmetic process for preventing or treating the signs of skin ageing or the orange-peel appearance |
| 06/16/2005 | WO2005054190A1 3-aminopyrrolidone derivatives |
| 06/16/2005 | WO2005053663A2 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
| 06/16/2005 | WO2005053610A2 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 06/16/2005 | WO2005016326A3 Analogs of thalidomide as potential angiogenesis inhibitors |
| 06/16/2005 | WO2004096286A3 Antiviral phosphonate analogs |
| 06/16/2005 | US20050131181 Isoprene-styrene copolymer, butadiene-styrene copolymer or butadiene-isoprene-styrene terpolymer randomly modified from 1-5%, e.g., of an p-(2-pyrrolidinoisopropyl-)styrene; tire tread; filler receptivity; low hysterises; rolling resistance; |
| 06/16/2005 | US20050131177 1-Alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators |
| 06/16/2005 | US20050131051 2-3-disubstituted quinuclidiness as modulators of monoamine transporters and theraperutic and diagnostic methods based thereon |
| 06/16/2005 | US20050131021 Phenoxy piperidines for treating diseases such as schizophrenia and depression |
| 06/16/2005 | US20050130981 Compounds |
| 06/16/2005 | US20050130972 Derivatives have a positive charge at the position corresponding to the anomeric position of a pyranose ring; active-site specific chaperones for mutant glucocerebrosidase |
| 06/16/2005 | US20050130966 Sodium channel modulators |
| 06/16/2005 | US20050130958 Substituted 6−membered n−heterocyclic compounds and their uses as neurological regulator |
| 06/16/2005 | US20050129676 Compounds and methods for modulating functions of classical cadherins |
| 06/16/2005 | CA2547356A1 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 06/16/2005 | CA2546653A1 3-aminopyrrolidone derivatives |
| 06/16/2005 | CA2542941A1 Analysis of mass spectral data in the quiet zones and label selection therefor |
| 06/15/2005 | EP1541590A1 Process for the oxidation of hydroxy compounds by means of nitroxy compounds |
| 06/15/2005 | EP1541552A1 Process for the recovery of nitroxy compounds from organic solutions and oxidation process |
| 06/15/2005 | EP1541147A1 Improved delivery of multiple doses of a methylphenidate drug |
| 06/15/2005 | EP1541143A1 Dpp-iv inhibitors |
| 06/15/2005 | EP1540037A1 Organic salts and their use as reagents in electrochemical reactions |
| 06/15/2005 | EP1539735A1 Piperazine urea derivatives as melanocortin-4 receptor agonists |
| 06/15/2005 | EP1539734A1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents |
| 06/15/2005 | EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 06/15/2005 | EP1539696A2 Process for preparing quinolin antibiotic intermediates |
| 06/15/2005 | EP1539695A1 N-4-piperidinyl compounds as ccr5 modulators |
| 06/15/2005 | EP1539686A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 06/15/2005 | EP1539160A1 Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders |
| 06/15/2005 | EP1539159A1 Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors |
| 06/15/2005 | EP1539158A1 Aryl piperidine derivatives as inducers of ldl-receptor expression for the treatment of hypercholesterolemia |
| 06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
| 06/15/2005 | EP1104412B1 Tace inhibitors |
| 06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 06/15/2005 | EP0923555B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 06/15/2005 | CN1628147A Fluorescent pigment composition |
| 06/15/2005 | CN1628112A Polymorph of acid 4-[2-[4-[1-2-ethoxyethyl)-1h-benzimidazole-2-il]-1-piper idinyl]ethyl]-dollar G (A), dollar G (A)-dimethyl-benzeneacetic |